SEC Filings TLDR

Lone Pine Capital LLC, along with its executive committee members, has filed a Schedule 13G indicating a 5% ownership stake in ETSY INC. The filing, dated October 24, 2025, reveals that Lone Pine Capital LLC holds 4,974,542 shares of ETSY INC's common stock, valued at approximately $367.5 million. The shares are held t...

North Reef Capital Management LP has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in Eagle Bancorp, Inc. As of September 30, 2025, North Reef Capital Management LP beneficially owns 2,632,918 shares, representing 8.7% of the outstanding common stock of Eagle Bancorp, Inc. This marks a sign...

Sanwei Liu, Xiaodong Liu, and Fixed Star Future Technology Ltd. have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 27,683,333 shares of common stock in CIMG Inc., representing 14.71% of the outstanding shares. The shares were acquired through a Business Cooperation Intent Agreement and a S...

RA Capital Management, L.P., along with Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P., filed a Schedule 13G with the SEC on October 24, 2025, disclosing beneficial ownership of 9,441,256 shares of common stock in C4 Therapeutics, Inc. This represents 9.9% of the company's outstanding shares. The f...

Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, and BCLS II Equity Opportunities, LP (collectively, the "Reporting Persons") have filed a Schedule 13G to report their beneficial ownership in C4 Therapeutics, Inc. As of the filing date, the Reporting Persons collectively own 7,171,910 shares...

ACR Alpine Capital Research, LLC, along with several affiliated entities, has filed a Schedule 13G indicating an increased ownership stake in Arrow Electronics, Inc. The filing reveals that ACR Alpine Capital Research now holds 2,633,060 shares, representing a 5.1% ownership in the company. This marks a significant inc...

Davidson Kempner Capital Management LP filed a Schedule 13G with the SEC on October 23, 2025, disclosing its ownership of 2,500,000 shares of Veritone, Inc.'s common stock, representing 2.9% of the total outstanding shares. The filing indicates that the shares were acquired for investment purposes and not with the inte...

Foresite Capital Fund VI LP, along with Foresite Capital Management VI, LLC and James Tananbaum, filed a Schedule 13G for Verastem, Inc. The filing indicates that the reporting persons collectively own 5.1% of Verastem's common stock, amounting to 3,135,120 shares. The shares are directly owned by Foresite Capital Fund...

Affinity Asset Advisors, LLC, along with Affinity Healthcare Fund, LP, has filed a Schedule 13G with the SEC, disclosing an increased stake in Sutro Biopharma, Inc. As of October 23, 2025, Affinity Asset Advisors, LLC beneficially owns 6,583,772 shares of Sutro Biopharma's Common Stock, representing 7.77% of the outsta...

The Schedule 13G filing reports the beneficial ownership of Class A Common Stock of Rani Therapeutics Holdings, Inc. by several entities and individuals, collectively referred to as the Reporting Persons. As of October 16, 2025, the Reporting Persons collectively beneficially owned 9,825,911 shares, representing 9.99% ...

Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC, Jane Street Options, LLC, and Jane Street Global Trading, LLC, has acquired a 5% stake in Hut 8 Corp. The total number of shares beneficially owned is 5,308,617, with a value of approximately $206,186,684. The filing, submitted under Rule 13d...

A Schedule 13G filing was submitted by Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander regarding their beneficial ownership of First Horizon Corporation's common stock. The filing indicates that these entities collectively own approximately 5% of ...

Syncracy Fund Management LLC, Syncracy Operational Management LLC, Daniel Cheung, and Ryan Watkins have collectively reported a 9.8% ownership in FG Nexus Inc. through Schedule 13G. Syncracy Fund Management LLC serves as the General Partner of Syncracy Master Fund I, Ltd, which holds the shares. Syncracy Operational Ma...

Glazer Capital, LLC, along with its Managing Member Paul J. Glazer, has filed a Schedule 13G indicating a 5.98% ownership stake in City Office REIT, Inc. The filing, dated October 23, 2025, reveals that Glazer Capital holds 2,412,926 shares of the company's common stock, valued at approximately $16,745,706. The shares ...

Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC, Jane Street Options, LLC, and Jane Street Global Trading, LLC, has reported a 5% ownership in Cipher Mining Inc. through a Schedule 13G filing. The group collectively owns 19,682,871 shares of Cipher Mining's common stock, valued at approxima...

Feis Equities LLC and Lawrence M. Feis have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 5.18% of the ordinary shares of Cayson Acquisition Corp. The filing, dated October 21, 2025, indicates that Feis Equities LLC and Lawrence M. Feis each hold 405,973 shares, representing sole voting an...

Tejara Capital Ltd has filed a Schedule 13G with the SEC, disclosing an increased ownership of 5.2% in Cardiol Therapeutics Inc. The filing indicates that Tejara Capital Ltd, a fund manager authorized by the FCA in the UK, now holds 5,130,122 Class A Common Shares plus 1,250,000 warrants. This represents a significant ...

Jane Street Group, LLC has filed a Schedule 13G with the SEC, disclosing a 5.4% ownership stake in Bitfarms Ltd. The filing, dated October 23, 2025, indicates that Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC, Jane Street Options, LLC, and Jane Street Global Trading, LLC, collectively ow...

Allan James Huang has reported beneficial ownership of 7,752,500 shares of iPower Inc.'s common stock, representing 24.6% of the total shares. Huang has sole voting and dispositive power over these shares. The filing, submitted on October 22, 2025, indicates that Huang is a United States citizen and resides at 705 Sout...

Merus Global Investments, LLC has filed a Schedule 13G with the SEC, reporting a 5.2% ownership in Spring Valley Acquisition Corp. II. The filing indicates that Merus Global Investments beneficially owns 510,125 Class A ordinary shares of the company. The shares are held solely by Merus Global Investments, with no shar...

ING Groep N.V. and its subsidiary ING Capital Markets LLC have filed a Schedule 13G with the SEC, reporting a 6.47% ownership in NEOGEN CORP. The filing indicates that both entities may be deemed beneficial owners of 14,060,900 shares of common stock as of August 31, 2025. The shares are held by ING Capital Markets LLC...

Tang Capital Management LLC, along with related entities and Kevin Tang, has filed a Schedule 13G indicating an increased stake in Keros Therapeutics, Inc. As of October 15, 2025, the reporting entities beneficially own 2,418,984 shares of Keros Therapeutics' Common Stock, representing a 7.9% ownership. This marks a si...

Biotechnology Value Fund, L.P. and related entities have filed a Schedule 13G disclosing their ownership in Invivyd, Inc. As of October 22, 2025, the entities collectively own approximately 7.4% of Invivyd's common stock. The filing includes Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnolo...

ING Groep N.V. and ING Capital Markets LLC have filed a Schedule 13G with the SEC, reporting a 6.47% ownership in NEOGEN CORP. The filing indicates that ING Groep N.V. and ING Capital Markets LLC may be deemed to be the beneficial owners of 14,060,900 shares of common stock. The shares are held by ING Capital Markets L...

Forsakringsaktiebolaget Avanza Pension, a Swedish insurance company, filed a Schedule 13G with the SEC, disclosing its ownership of 320,536 shares of Hyperion DeFi's common stock, representing 5.62% of the total shares. The filing indicates that the shares were acquired and are held in the ordinary course of business, ...